| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/05/2007 | US7226759 Immunoglobulins; Chinese hamster ovary cell lines; site-directed mutagenesis; improved pharmacokinetics and pharmacodynamics; side effect reduction |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226756 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling |
| 06/05/2007 | US7226754 Controlling cell cycles; isolation nucleotide sequences; genetic engineering |
| 06/05/2007 | US7226745 Plant vitamin E biosynthetic enzymes |
| 06/05/2007 | US7226742 Method for detecting base mutation |
| 06/05/2007 | US7226737 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 06/05/2007 | US7226735 Transgenic saccharomyces expressing xylulokinase for use in fermentation ethanol; conversion of cellullosic material into alternative fuel sources |
| 06/05/2007 | US7226732 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 06/05/2007 | US7226618 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 06/05/2007 | US7226601 binds to both the T cell receptor and an MHC class II antigen; superantigen peptide and affinity counterpart are covalently linked; conjugates have the ability to activate and direct T-lymphocytes |
| 06/05/2007 | US7226597 Vaccine for humans, animals; forming antibodies; genetic engineering; mutant polypeptide |
| 06/05/2007 | US7226596 Metalloenzymes; antiproliferative agents; anticarcinogenic agents; cancer diagnosis; antisense agents; complementary determining regions |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 06/05/2007 | US7226589 Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor |
| 06/05/2007 | US7226588 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 06/05/2007 | US7226587 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing |
| 06/05/2007 | CA2568097A1 Taar1 transgenic animals |
| 06/05/2007 | CA2394018C Bzip transcription factor that controls expression of the storage protein in the rice plant |
| 06/05/2007 | CA2332310C Antibody against protein tyrosine phosphatase intracellular domains |
| 06/05/2007 | CA2320666C 5' nucleases derived from thermostable dna polymerase |
| 06/05/2007 | CA2284555C Probes for the diagnosis of infections caused by streptococcus pyogenes |
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2214431C Human vegf-specific antisense oligonucleotides |
| 06/05/2007 | CA2181165C Anti-fungal methods and materials |
| 06/05/2007 | CA2143442C Dorsal tissue affecting factor and compositions |
| 06/05/2007 | CA2128530C Method for use of branched nucleic acid probes |
| 06/05/2007 | CA2110938C Modified proteins containing controllable intervening sequences and methods of their production |
| 06/05/2007 | CA2080812C Hybridization probes derived from the spacer region between the 16s and 23s rrna genes for the detection of non-viral microorganisms |
| 06/05/2007 | CA2056396C The expression of phytase in plants |
| 06/02/2007 | WO2008085147A2 Novel plant virus particles and methods of inactivation thereof |
| 06/02/2007 | CA2632245A1 Novel plant virus particles and methods of inactivation thereof |
| 06/02/2007 | CA2533219A1 Systems and methods for automated proteomics research |
| 05/31/2007 | WO2007062380A2 Modulation of eif4e-bp2 expression |
| 05/31/2007 | WO2007062107A2 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | WO2007062101A2 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | WO2007062064A2 Methods and compositions for controlling parasitic infections with bt crystal proteins |
| 05/31/2007 | WO2007061845A2 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/31/2007 | WO2007061759A1 Delayed expression vectors |
| 05/31/2007 | WO2007061742A1 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/31/2007 | WO2007061679A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/31/2007 | WO2007061274A1 Universal kit for cell lysis |
| 05/31/2007 | WO2007061141A1 Mutant paramyxovirus and method for production thereof |
| 05/31/2007 | WO2007061136A1 Method for production of protein having non-natural type amino acid integrated therein |
| 05/31/2007 | WO2007061128A1 Method for enzymatic modification of n-terminus of protein |
| 05/31/2007 | WO2007061077A1 Carrier for use in introduction of nucleic acid, kit for use in introduction of nucleic acid, and method for introduction of nucleic acid into cell |
| 05/31/2007 | WO2007061053A1 Hybrid promoter composed of muscle-tropic promoter and sv40 virus promoter and vector carrying the hybrid promoter |
| 05/31/2007 | WO2007061022A1 Mitochondrial function of prohibitin 2 (phb2) |
| 05/31/2007 | WO2007060979A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 05/31/2007 | WO2007060949A1 Method for detection and amplification of nucleic acid |
| 05/31/2007 | WO2007060899A1 Application of actin-binding protein to disease associated with cell motility |
| 05/31/2007 | WO2007060864A1 Antibody-producing precursor b cell whose growth and differentiation can be controlled |
| 05/31/2007 | WO2007060769A1 Lipopolysaccharide or lipid a binder and novel peptide |
| 05/31/2007 | WO2007060764A1 Method for gene amplification |
| 05/31/2007 | WO2007060725A1 Recombinant polyvalent vaccine |
| 05/31/2007 | WO2007060715A1 Method of screening interleukin-6 (il-6) signal transduction inhibitor |
| 05/31/2007 | WO2007060514A2 Methods and compositions for modulating root growth in plants |
| 05/31/2007 | WO2007060411A1 Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r |
| 05/31/2007 | WO2007060406A1 Bioassays |
| 05/31/2007 | WO2007060248A1 Method of isolating nucleic acids from any starting material |
| 05/31/2007 | WO2007060247A2 Enzyme preparations yielding a clean taste |
| 05/31/2007 | WO2007060240A2 Method for demonstrating presence or absence of markers (eef1a1 or mark3 )associated with the presence and/or the chemosensitivity of tumors |
| 05/31/2007 | WO2007060213A2 Erythropoietin polypeptides and uses thereof |
| 05/31/2007 | WO2007060117A2 Chimeric keratin-binding effector proteins |
| 05/31/2007 | WO2007059927A1 Use of a thermostable phospholipase in the degumming of an oil or fat, and a method for obtaining a thermostable phospholipase |
| 05/31/2007 | WO2007059760A1 Dna constructs for specific inhibition of gene expression by rna interference |
| 05/31/2007 | WO2007059715A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | WO2007059612A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | WO2007059605A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 05/31/2007 | WO2007059574A1 A molecule and chimeric molecules thereof |
| 05/31/2007 | WO2007041536A3 Modulating plant tocopherol levels |
| 05/31/2007 | WO2007041439A9 Centrosomal proteins, nucleic acids and method of use thereof |
| 05/31/2007 | WO2007038130A3 Improved strains for the production of organic acids |
| 05/31/2007 | WO2007037560A9 Therapeutic or diagnostic application of sgk2 gene |
| 05/31/2007 | WO2007037555A9 Therapeutic or diagnostic application of dusp15 gene |
| 05/31/2007 | WO2007037550A9 Therapeutic or diagnostic application of tsta3 gene |
| 05/31/2007 | WO2007037538A9 Therapeutic or diagnostic application of spo11 gene |
| 05/31/2007 | WO2007037533A9 Therapeutic or diagnostic application of ppp1r3d gene |
| 05/31/2007 | WO2007037532A9 Therapeutic or diagnostic application of srms gene |
| 05/31/2007 | WO2007035742A9 Cdna library preparation |
| 05/31/2007 | WO2007034169A3 Cell selection and reporter system |
| 05/31/2007 | WO2007029271A3 Glutathione-s-transferase gene from proposis juliflora confers abiotic stress tolerance in plants |
| 05/31/2007 | WO2007027894A3 Antisense compounds having enhanced anti-microrna activity |
| 05/31/2007 | WO2007019444A3 Subtractive separation and amplification of non-ribosomal transcribed rna (nrrna) |
| 05/31/2007 | WO2007015267A3 Dehydrin gene from avicennia marina responsible for conferring salt tolerance in plants |
| 05/31/2007 | WO2007014469A8 Hepatitis c antivirals |
| 05/31/2007 | WO2007014181A3 Site-specific modification of the human genome using custom-designed zinc finger nucleases |
| 05/31/2007 | WO2007011975A3 Methods to express recombinant proteins from lentiviral vectors |
| 05/31/2007 | WO2007008546A3 High tryptophan soybean meal |
| 05/31/2007 | WO2006136607A3 Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry |
| 05/31/2007 | WO2006133457A3 Bone morphogenetic variants, compositions and methods of treatment |
| 05/31/2007 | WO2006133079A3 Increasing perhydrolase activity in esterases and/or lipases |
| 05/31/2007 | WO2006131936B1 Hepatitis c virus vaccine |
| 05/31/2007 | WO2006120019A3 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
| 05/31/2007 | WO2006119627A8 Enhancing vegetative protein production in transgenic plants using seed specific promoters |
| 05/31/2007 | WO2006117582A3 Export of recombinant proteins by flagellar export apparatus |
| 05/31/2007 | WO2006116458A3 Modified oligoribonucleotide analogs with enhances immunostimulatory activity |
| 05/31/2007 | WO2006113214A3 Vaccine against pandemic strains of influenza viruses |
| 05/31/2007 | WO2006091219A3 Methods of protecting plants from pathogenic fungi |
| 05/31/2007 | WO2006089329A3 Mutant aox 1 promoters |